SI-BONE rises as prelim Q4, FY revenue above expectations

SI-BONE

09/01/2023 18:50

** Shares of medical device company SI-BONE Inc  SIBN.O 
rise 7.6% to $13.7
    ** Co sees Q4 worldwide revenue in range of $31.7 mln-$31.9
mln, representing 26% growth vs prior year; also above analyst's
expectations of $30.1 mln - Refinitiv data  urn:newsml:reuters.com:*:nGNX2kk6d0
    ** SIBN expects FY 2022 worldwide revenue to be in range of
$106.1 mln-106.3 mln vs analysts view of $104.6 mln
    ** Co says it ended the quarter with a record 920 active
surgeons in the U.S., representing growth of nearly 33% vs a
year ago period
    ** All 8 brokerages covering the stock rate it "buy" or
higher; their median PT is $20.50
    ** In 2022, stock fell 38.8% 
 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))